To examine the efficacy of mmLbL-INS microspheres in diabetes treatment, STZ-induced diabetic rats were subcutaneously injected with PBS solution, CaCO3-INS (0.035 mg/ml INS), and mmLbL-INS microspheres (1 mg/ml INS). The gene discussed is INS; the disease is diabetes mellitus.